Australia markets closed

Encompass Health Corporation (EHC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
82.47-0.26 (-0.31%)
At close: 04:00PM EDT
82.47 0.00 (0.00%)
After hours: 05:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.26B
Enterprise value 11.04B
Trailing P/E 21.59
Forward P/E 20.92
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.69
Price/book (mrq)4.74
Enterprise value/revenue 2.23
Enterprise value/EBITDA 10.40

Trading information

Stock price history

Beta (5Y monthly) 0.83
52-week change 328.30%
S&P500 52-week change 322.36%
52-week high 385.84
52-week low 357.55
50-day moving average 378.08
200-day moving average 370.22

Share statistics

Avg vol (3-month) 3711.91k
Avg vol (10-day) 3820.99k
Shares outstanding 5100.14M
Implied shares outstanding 6100.14M
Float 898.39M
% held by insiders 11.43%
% held by institutions 1100.59%
Shares short (15 Apr 2024) 42.2M
Short ratio (15 Apr 2024) 42.87
Short % of float (15 Apr 2024) 42.49%
Short % of shares outstanding (15 Apr 2024) 42.20%
Shares short (prior month 15 Mar 2024) 42.29M

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 40.73%
Trailing annual dividend rate 30.60
Trailing annual dividend yield 30.73%
5-year average dividend yield 41.50
Payout ratio 415.71%
Dividend date 315 Apr 2024
Ex-dividend date 428 Mar 2024
Last split factor 21257:1000
Last split date 301 July 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 7.60%
Operating margin (ttm)15.77%

Management effectiveness

Return on assets (ttm)7.94%
Return on equity (ttm)22.94%

Income statement

Revenue (ttm)4.96B
Revenue per share (ttm)49.77
Quarterly revenue growth (yoy)13.40%
Gross profit (ttm)N/A
EBITDA 1.04B
Net income avi to common (ttm)386.7M
Diluted EPS (ttm)3.82
Quarterly earnings growth (yoy)28.30%

Balance sheet

Total cash (mrq)134.4M
Total cash per share (mrq)1.35
Total debt (mrq)2.92B
Total debt/equity (mrq)121.47%
Current ratio (mrq)1.37
Book value per share (mrq)17.45

Cash flow statement

Operating cash flow (ttm)861.7M
Levered free cash flow (ttm)76.4M